Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$149.29−0.74 (-0.49%)
Close on Nov 12, 2026Market cap $10.35BP/E 24.3Yield –
Insulet price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Insulet's price to book ratio was 7.4× on Nov 11, 2026, against 17.1× a year earlier. Over the last 5 years it ranged from 6.4× to 48.6×, with a median of 17.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.4× | −7.5 |
| 2025 | Dec 31, 2025 | 14.9× | −1.5 |
| 2024 | Dec 31, 2024 | 16.4× | −8.6 |
| 2023 | Dec 29, 2023 | 24.9× | −22.8 |
| 2022 | Dec 30, 2022 | 47.8× | +10.9 |
| 2021 | Dec 31, 2021 | 36.8× | +8.5 |
| 2020 | Dec 31, 2020 | 28.3× | −41.9 |
| 2019 | Dec 31, 2019 | 70.2× | +46.6 |
| 2018 | Dec 31, 2018 | 23.7× | −30.4 |
| 2017 | Dec 29, 2017 | 54.0× | +20.8 |
| 2016 | Dec 30, 2016 | 33.2× | −5.8 |
| 2015 | Dec 31, 2015 | 39.0× | +6.9 |
| 2014 | Dec 31, 2014 | 32.1× | +15.5 |
| 2013 | Dec 31, 2013 | 16.7× | −3.6 |
| 2012 | Dec 31, 2012 | 20.2× | +10.8 |
| 2011 | Dec 30, 2011 | 9.4× | – |
See a number that looks wrong?